Efficacy and Safety of Reslizumab in Patients with Severe Asthma with Inadequate Response to Omalizumab: A Multicenter, Open-Label Pilot Study.

Pérez de Llano, Luis A

Efficacy and Safety of Reslizumab in Patients with Severe Asthma with Inadequate Response to Omalizumab: A Multicenter, Open-Label Pilot Study. [electronic resource] - The journal of allergy and clinical immunology. In practice - 2277-2283.e2 p. digital

Publication Type: Controlled Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't

2213-2201

10.1016/j.jaip.2019.01.017 doi


Adult
Anti-Asthmatic Agents--adverse effects
Antibodies, Monoclonal, Humanized--adverse effects
Asthma--drug therapy
Female
Humans
Male
Middle Aged
Omalizumab--therapeutic use
Pilot Projects
Treatment Outcome